METHOD FOR PREDICTING THE DEVELOPMENT OF POST-COVID SYNDROME IN PATIENTS WITH MILD (CT-I) COVID-19-ASSOCIATED PNEUMONIA Russian patent published in 2024 - IPC A61B5/26 A61B5/91 A61B5/01 

FIELD: medicine; therapy; pulmonology; rehabilitation.

SUBSTANCE: invention relates to infectious diseases and can be used in predicting the development of post-COVID syndrome in patients with mild (CT-I) COVID-19-associated pneumonia. Blood flow type is determined by laser Doppler flowmetry, lung capacity and clinical parameters are assessed. Presence of dyspnea on admission to hospital, degree of body temperature increase is also assessed. Derived values are evaluated in points. And if the total score is from 0 to 3, a low risk of developing post-COVID syndrome is predicted, and if the total score is from 4 to 6 points, a high risk of developing post-COVID syndrome is predicted.

EFFECT: method enables to implement a personalized approach to further treatment and rehabilitation of patients due to the possibility of detecting the probability of developing post-COVID syndrome by assessing the set of the most significant indicators.

1 cl, 5 tbl, 4 ex